Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha.

Source:http://linkedlifedata.com/resource/pubmed/id/10335485

Download in:

View as

General Info

PMID
10335485